1. Introduction {#s0005}
===============

Alzheimer\'s disease (AD) is a severe neurodegenerative disorder characterized by diffuse brain atrophy along with progressive decline in multiple cognitive domains. In recent years, the pathophysiological model of AD has been redefined along a disease continuum where the neuropathological changes, such as cerebral amyloid beta (Aβ) deposition, have been shown to precede any detectable cognitive manifestation by two or three decades ([@bb0370]). Therefore, tremendous effort has been made in order to elucidate the link between the pathological cascade of AD and the emergence of cognitive symptoms ([@bb0210]).The *APOE*-ε4 allele represents the major genetic risk factor for sporadic AD by lowering the age of onset in a gene dose-dependent manner ([@bb0255]). *APOE*-ε4 codes the apolipoprotein-ε4 (apoE4), which compared to other isoforms, is less effective in maintaining cerebral lipid homeostasis and in breaking down amyloid beta (Aβ) peptide, thus facilitating the formation of extracellular insoluble oligomers ([@bb0425]). Cognitively intact *APOE*-ε4 carriers show higher cerebral Aβ deposition ([@bb0215]; [@bb0335]) as well as lower cerebral metabolism ([@bb0330]), with these effects being proportional to the number of ε4 alleles. Previous studies have also reported an impact of the risk variant on cerebral morphology in healthy individuals ([@bb0005]; [@bb0205]; [@bb0385]) although this has not always been confirmed ([@bb0315]; [@bb0275]; [@bb0170]; see [@bb0145] for a review). Recently, using a spatially unbiased voxel-wise approach in a sample harboring a high number of healthy *APOE*-ε4 homozygous, we have reported dose--dependent effects of the risk allele on the volume of several AD-sensitive areas ([@bb0055]). Yet, the underlying mechanisms through which *APOE*-ε4 posits increased risk for AD are not fully understood, and its impact on cognitive performance in unaffected individuals remains unclear. Previous seminal works reported a gene dose-dependent lifetime decline in episodic memory (EM) ([@bb0065]) but not in executive functions (EFs) ([@bb0070]) in cognitively unimpaired *APOE*-ε4 carriers compared to non-carriers, even though other studies could not confirm such a longitudinal association ([@bb0045]). Similarly, cross-sectional studies reported either worse ([@bb0290]; [@bb0205]), better ([@bb0275]), or equivalent ([@bb0260]; [@bb0325]) cognitive functioning in healthy carriers of the risk allele compared to non-carriers. Divergence among studies may depend on the age of the participants ([@bb0220]) as well as the amyloid status, since the detrimental impact of *APOE*-ε4 in healthy individuals has been shown to occur in Aβ-positive individuals only ([@bb0250]).

Besides genetic liability, the greatest unmodifiable AD risk factor is represented by advanced age. Recently we have reported that, irrespective of the *APOE* status, aging modulates the relationship between cognitive performance (*i.e.*, both EM and EFs) and regional brain volumes in healthy participants, with older individuals displaying reversed associations compared to younger ones in medial temporal and prefrontal areas ([@bb0060]). Since *APOE*-ε4 has been proposed to confer an accelerated aging process ([@bb0055]; [@bb0125]; [@bb0140]), one possibility is that, although not significantly affecting cognitive performance in the healthy population, the ε4 allele would modify the association between cognitive performance and the underlying brain morphology in a similar way as exerted by aging. This assumption is also supported by earlier functional neuroimaging studies which showed that *APOE*-ε4 modulates the relationship between cognitive performance and patterns of brain activity ([@bb0260]; [@bb0125]; [@bb0140]; [@bb0020]; [@bb0025]) as well as cerebral Aβ deposition in healthy individuals ([@bb0225]).

In the present study we sought to determine whether this modulatory role is extendable to the brain structural level. We predicted that *APOE*-ε4 would shift the associations between regional GMv and cognitive performance in both EM and EFs. We tested our hypotheses on a sample of middle-aged cognitively healthy individuals which was enriched for the genetic risk for AD, hosting a significantly higher number of *APOE*-ε4 homozygous than previously reported in single-site neuroimaging studies of healthy subjects (*N* = 64). This sample characteristic allowed us testing separate genotypic models which may capture distinct biological pathways for the risk allele to confer AD liability, as previously suggested in structural neuroimaging studies of AD patients ([@bb0135]) and healthy controls ([@bb0055]).

2. Methods {#s0010}
==========

2.1. Study participants {#s0015}
-----------------------

All subjects were enrolled in the ALFA (ALzheimer and FAmilies) study ([Clinicaltrials.gov](http://Clinicaltrials.gov){#ir0005} Identifier: [NCT01835717](NCT01835717){#ir0010}), a large cohort program pointing to the identification of pathophysiological alterations in preclinical AD comprising 2743 study participants ([@bb0270]). Participants were cognitively unimpaired with a Clinical Dementia Rate score of 0. Subjects with disorders which could interfere with cognition or with a psychiatric diagnosis were excluded from the study. Additional exclusion criteria have been described in detail previously ([@bb0270]). After *APOE* genotyping, all participants homozygous for the ε4 allele as well as carriers of the ε2 allele were invited to undergo magnetic resonance imaging (MRI) scanning along with ε4-heterozygous and non-carriers matched for age and sex. This recruitment strategy resulted in 576 study participants, out of which 43 had to be discarded due to MRI incidental findings or poor image quality. From the remaining 533 individuals, 6 subjects were discarded due to missing cognitive data, yielding to a final sample of 527 subjects. For the statistical analyses participants were pooled according to the cumulative presence of the ε4 allele, that is in non-carriers (NC), ε4-heterozygous (HE) and ε4-homozygous (HO). The study was approved by the local ethics committee, and all participants gave written informed consent to participate in the study.

2.2. *APOE* genotyping {#s0020}
----------------------

Total DNA was obtained from blood cellular fraction by proteinase K digestion followed by alcohol precipitation. Samples were genotyped for two single nucleotide polymorphisms (SNPs), rs429358 and rs7412, determining the possible APOE isoforms: ε1, rs429358 (C) + rs7412 (T); ε2, rs429358 (T) + rs7412 (T); ε3, rs429358 (T) + rs7412 (C); and ε4, rs429358 (C) + rs7412 (C). Of the 527 participants, 162 were ε3/ε4 carriers, 149 were homozygous for the ε3 allele, 104 were ε2/ε3 carriers, 64 were homozygous for the ε4 allele, 42 were ε2/ε4, and 6 were ε2/ε2 carriers. The allele frequencies did not significantly deviate from Hardy-Weinberg equilibrium (*χ*^2^ = 5.99, *p* = .20).

2.3. Image data acquisition and preprocessing {#s0025}
---------------------------------------------

Magnetic resonance imaging (MRI) was conducted with a 3 T General Electric scanner (GE Discovery MR750 W). Structural 3D high-resolution T~1~-weighted images were collected using a fast spoiled gradient-echo (FSPGR) sequence implementing the following parameters: voxel size = 1 mm^3^ isotropic, Repetition Time (TR) = 6.16 ms, Echo Time (TE) = 2.33 ms, inversion time (TI) = 450 ms, matrix size = 256 × 256 × 174, flip angle = 12°. Gray matter (GM) was segmented from images using the new segment function implemented in Statistical Parametrical Mapping software (SPM 12, Wellcome Department of Imaging Neuroscience, London, UK), and located into a common space for subsequent normalization using a 12-affine parameter transformation. Segmented GM images were used to generate a reference template of the sample, which was warped into a standard Montreal Neurological Institute (MNI) space using the high dimensional DARTEL toolbox ([@bb0010]). The generated flow fields and normalization parameters were then implemented to normalize the native GM images to the MNI space. In order to preserve the native local amount of GM volume, we applied a modulation step, where each voxel signal\'s intensity was multiplied by the Jacobian determinants derived from the normalization procedure ([@bb0175]). Quality control of normalization was assured by checking the sample homogeneity with the computational anatomy toolbox (CAT12) (<http://dbm.neuro.uni-jena.de/cat/>) using non-smoothed data, which did not return errors in the registration procedure in any subject. Finally, images were spatially smoothed with a 6 mm full-width at half maximum (FWHM) Gaussian kernel. Total intracranial volume (TIV) was computed by summing the segmented GM, white matter (WM) and cerebrospinal fluid (CSF) volumes for each individual.

2.4. Neuropsychological evaluation {#s0030}
----------------------------------

The neuropsychological assessment took place on average 10.6 months (SD = 5.81) before the MRI session. EM was assessed using the Spanish adapted version of the Memory Binding Test (MBT) ([@bb0180]), an instrument that was developed for detecting subtle memory impairment in the cognitively intact population ([@bb0050]). Previous studies have demonstrated the ability of the MBT (formerly referred as Memory Capacity Test \[MCT\]) to discriminate subjects with cerebral Aβ deposition ([@bb0305]), and to successfully predict the incidence of MCI longitudinally ([@bb0280]). During administration, subjects sequentially learn two lists of 16 words written in cards, where each card contains four words. The lists share semantic categories, which are used both to control the encoding of the words in learning and as cues during cued recall trials. After the presentation of each list, immediate cued recall (CR) of the presented items is tested, to provide a measure of successful encoding. Four main outcomes are produced: Total Paired Recall (TPR), which is the recall of both lists after semantic cueing; Total Free Recall (TFR), for the free recall of both lists; Total Delayed Paired Recall (TDPR), for the delayed (30 min after initial recall) after semantic cueing; and Total Delayed Free Recall (TDFR), for the delayed counterpart of the free recall. As a measure of cued memory retention, we computed the percentage of loss of learnt words over to two different time-laps. This was achieved by dividing TPR and TDPR scores by scores for immediate cued recall (CR), respectively. This procedure generated two different retention index scores: short-delay retention (SDR) and long-delay retention (LDR). The former (SDR) covered a time-lap of approximately 5 min (*i.e.*, the time between the end of CR and the last recalled word in TPR), while the latter (LDR) covered a lap of approximately 30 min (*i.e.*, the time between the end of CR and the last recalled word in TDPR).

EFs were assessed using the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV, [@bb0400]). We administered five subtests: Coding (cognitive processing speed), Digit Span (working memory), Matrix Reasoning (non-verbal problems solving), Visual Puzzles (visuospatial processing), and Similarities (verbal reasoning and abstract thinking). Digit Span subtests were studied separately as previously recommended ([@bb0085]) (Digit-span forward, Digit-span backward, Digit-span sequencing).

2.5. Statistical analysis {#s0035}
-------------------------

Group differences in demographic variables were assessed with a one-way analysis of variance or a chi-squared test for continuous or categorical variables, respectively.

To assess group differences in cognitive performance we conducted an analysis of covariance (ANCOVA) separately for each outcome, where *APOE*-ε4 status was entered as a between-subject factor, while age, sex and years of education were modelled as covariates. Since *APOE*-ε4 influences the age-related cognitive decline in healthy individuals ([@bb0065], [@bb0070]), we further modelled the interaction between *APOE* status and age. Statistical threshold for significance was set to α \< 0.05. Structural imaging data were analyzed using Statistical Parametric Mapping software (SPM12, Wellcome Department of Imaging Neuroscience, London, UK). The normalized, modulated and smoothed GM images were entered in a multiple regression design within the general linear model (GLM) implemented in SPM12. To determine the structural brain correlates of EM and EFs in the entire sample, we modelled the effect of each cognitive outcome separately, further controlling for the effects of age, sex, years of education and TIV. To assess the impact of *APOE*-ε4 in modulating the relationship between cognitive performance and regional GMv, we performed a separate GLM, where the variability in cognitive performance was modelled separately for each *APOE*-ε4 subgroup, namely non-carriers (NC), ε4-heterozygous (HE) and ε4-homozygous (HO). This procedure resulted in the inclusion of 3 orthogonal regressors coding the interaction between *APOE* status and cognitive performance. Next, different t-contrasts were performed to test the distinct models of genetic penetrance, namely the dominant, recessive and additive effects, as proposed for the analysis of quantitative trait loci ([@bb0080]). Briefly, an additive model predicts an incremental response of the quantitative trait according to the allelic load, whereas a dominant model predicts a common response to 1 or 2 copies of the risk allele (*i.e.*, ε4-carriers *vs.* non-carriers). Finally, a recessive model predicts a common response to 0 or 1 copy of the risk allele (*i.e.*, non-carriers and ε4-heterozygotes *vs.* ε4-homozygotes). This approach was already implemented in neuroimaging studies investigating the impact of the *APOE* genotype on brain morphology ([@bb0055]; [@bb0135]). Results were considered significant if surviving a whole-brain voxel-wise statistical threshold of *p* \< .001 applying a cluster extent threshold correction of 100 contiguous voxels. This procedure is reliably conservative and further protects against Type I error ([@bb0165]).

Finally, to reduce dimensionality and to search for common patterns of brain morphology associated to EM and EFs, we additionally performed a principal component analysis (PCA) separately for the two cognitive domains and repeated all the above analyses using the extracted principal components as dependent variables ([@bb0150]).

3. Results {#s0040}
==========

3.1. Sample demographic characteristics {#s0045}
---------------------------------------

[Table 1](#t0005){ref-type="table"} summarizes the demographic characteristics of our sample. The *APOE* genotype groups did not differ in TIV, male/female ratio, or years of education. There was, however, a significant difference in age with the ε4-homozygous being younger than both non-carriers and ε4-heterozygous. For this reason, age was included as covariate in all subsequent analyses.Table 1Sample demographic characteristics.Table 1NC (*N* = 259)HE (*N* = 204)HO (N = 64)Inferential statisticsAge[a](#tf0005){ref-type="table-fn"} (SD)57.97 (7.55)58.23 (7.45)53.97 (6.07)*F* = 8.85; *P* \< .01Education[a](#tf0005){ref-type="table-fn"} (SD)13.68 (3.62)13.68 (3.53)13.44 (3.46)*F* = 0.13; *P* = .88TIV[b](#tf0010){ref-type="table-fn"} (SD)1448.75 (155.75)1496.64 (137.84)1493.82 (136.26)*F* = 0.39; *P* = .67Male/female (n)95/16493/11124/40*χ*^2^ = 3.99; *P* = .14[^1][^2][^3]

3.2. APOE genotype and cognitive performance {#s0050}
--------------------------------------------

[Table 2](#t0010){ref-type="table"} displays main effects of our independent predictors (*i.e.*, *APOE*-ε4, age, sex, and years of education) as well as the interaction between *APOE*-ε4 and age on cognitive performance in EM and EFs. None of the three genotypic models yielded significant main effects of *APOE*-ε4 on EM or EFs performance. Irrespective of the genetic model of penetrance, immediate as well as delayed recall performance significantly declined with increasing age, however both short- and long-delay retention did not show an age-related decline ([Table 2](#t0010){ref-type="table"}; Supplementary Fig. 3). All measures of EFs showed a significant age-related effect except the digit-span forward and digit-span backward ([Table 2](#t0010){ref-type="table"}). Additionally, while female subjects performed better in recall performance, males obtained significantly higher scores in EFs ([Table 2](#t0010){ref-type="table"}; Supplementary Fig. 3). A confirmatory analysis performed on the first principal component for each cognitive domain yielded similar results (Supplementary Table 1).Table 2Cognitive performance in the whole sample assessed for each subtest.Table 2*APOE*-ε4 statusAge(y)*APOE x* AgeSexEducation(y)*F*P*F*P*F*P*F*P*F*PDominant modelTPR2.990.0811.35\<0.012.410.124.330.0420.44\<0.01TFR2.350.1235.77\<0.012.220.136.010.0212.18\<0.01TDPR1.810.1811.48\<0.011.350.244.960.0321.58\<0.01TDFR0.650.4239.06\<0.010.390.535.510.0239.06\<0.01SDR0.010.933.290.070.010.953.470.0610.83\<0.01LDR0.110.732.270.130.160.686.460.0111.72\<0.01Coding0.190.67118.7\<0.010.130.710.940.3367.24\<0.01DSF0.010.972.370.120.020.8825.57\<0.0124.80\<0.01DSB0.860.356.760.010.690.4017.04\<0.0132.10\<0.01DSS0.380.5316.74\<0.010.360.5523.31\<0.0133.51\<0.01Matrix0.830.3652.93\<0.010.830.365.100.0294.25\<0.01Similarities0.320.578.25\<0.010.230.628.97\<0.01126.4\<0.01VP0.330.5640.31\<0.010.260.6147.88\<0.0143.70\<0.01Recessive modelTPR0.990.320.560.451.390.233.870.0520.25\<0.01TFR0.010.949.05\<0.010.040.845.740.0112.23\<0.01TDPR1.140.280.520.461.540.214.520.0321.42\<0.01TDFR0.010.949.98\<0.010.040.835.000.0217.07\<0.01SDR2.710.100.040.822.470.113.480.0610.34\<0.01LDR0.620.430.200.650.400.526.480.0111.18\<0.01Coding0.860.3526.01\<0.010.980.321.100.2967.64\<0.01DSF1.810.170.180.672.130.1426.43\<0.0124.68\<0.01DSB0.150.690.660.410.330.5617.77\<0.0132.49\<0.01DSS0.100.744.850.030.020.8923.89\<0.0134.37\<0.01Matrix0.020.8816.07\<0.100.010.935.060.0294.80\<0.01Similarities0.370.541.210.270.360.549.27\<0.01125.2\<0.01VP0.130.7113.16\<0.010.080.7747.57\<0.0144.49\<0.01Additive modelTPR2.440.082.750.082.430.084.540.0320.50\<0.01TFR1.060.3417.67\<0.011.090.335.940.0112.28\<0.01TDPR1.870.152.540.101.880.155.090.0221.63\<0.01TDFR0.260.7719.01\<0.010.200.815.420.0217.14\<0.01SDR1.710.180.210.641.500.223.860.0510.41\<0.01LDR0.340.710.800.370.210.806.89\<0.0111.23\<0.01Coding0.470.6252.09\<0.010.500.610.940.3367.32\<0.01DSF0.980.370.010.911.110.3325.21\<0.0124.75\<0.01DSB0.430.641.940.160.500.6017.16\<0.0132.47\<0.01DSS0.080.928.36\<0.010.050.9523.86\<0.0134.22\<0.01Matrix0.640.5227.42\<0.010.610.545.260.0294.53\<0.01Similarities0.570.563.210.070.490.618.65\<0.01125.2\<0.01VP0.510.5921.67\<0.010.390.6748.57\<0.0144.28\<0.01[^4]

3.3. Impact of *APOE*-ε4 on the associations between EM performance and GMv {#s0055}
---------------------------------------------------------------------------

Supplementary Table 2 displays the brain volumetric correlates of cognitive performance in the whole sample, which are in line with our previous study conducted on a subsample of the present one ([@bb0060]). We detected significant interactions between EM performance and *APOE* status in all the MBT outcomes, indicating that *APOE-*ε4 significantly modified the relationships between EM proficiency and gray matter morphology ([Table 3](#t0015){ref-type="table"}). [Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"} display these effects in selected brain regions separately for paired and free recall. The dominant, recessive and additive models mapped onto shared brain areas, such as the inferior temporal gyrus, the dorsal anterior cingulate cortex as well as the cuneus for the TFR, and the basal forebrain cholinergic nuclei for the TDPR. For TDFR, the recessive and the additive models shared several regions including the inferior superior temporal cortex, the precuneus and the posterior cingulate gyrus. The shared topology among different genotypic contrasts in some areas does not assure that variability in that specific region is equally summarized by those contrasts. To provide statistical evidence of this, we performed a conjunction analysis in SPM asking for all common brain regions in pairs of t-contrasts (*i.e.*, dominant-recessive, dominant-additive, recessive-additive). Results show that for most cognitive outcomes, there are no shared brain regions between the dominant and the recessive models (Supplementary Table 3). [Table 4](#t0020){ref-type="table"} and [Fig. 3](#f0015){ref-type="fig"} illustrate significant interaction effects for short as well as long-delay retention index (SDR, LDR). In both retention indices, there were no shared brain regions between the dominant and the recessive models, suggesting that these two genotypic models captured distinct biological mechanisms. For SDR, the dominant and the additive models revealed significant interactions in the right and left hippocampus as well as the bilateral insula and the posterior cingulate, with these effects additionally surviving correction for multiple testing on the cluster level (using a family-wise error rate \[FWE\] approach). For LDR, the dominant model yielded significant effects in the middle and posterior cingulate cortex as well as the bilateral insula and the inferior parietal cortex. By contrast, the recessive model mapped onto different regions, such as the entorhinal cortex as well as the superior frontal cortex and the cerebellum (lobule 8). In all brain regions *APOE*-ε4 carriership shifted the association between EM performance and regional GMv from being negative to positive ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}).Table 3*APOE*-ε4 significantly modulated the relationship between EM performance and regional GMv.Table 3Brain regionLaterality*t*-value[⁎](#tf0015){ref-type="table-fn"}k[⁎⁎](#tf0020){ref-type="table-fn"}MNI coordinatesxyzEpisodic Memory TPR *ε4*-dominantMiddle frontalR4.55135332933Dorsal anterior cingulateL4.46290−92736Insula[a](#tf0025){ref-type="table-fn"}L4.29618−35−1414PrecuneusL4.003160−5632InsulaR4.0029941−1111Basal forebrainR3.9710315−3−12Frontal operculumR3.96105411512Basal forebrainL3.86365−93−15 *ε4*-recessivePosterior cingulateL3.711270−4124 *ε4*-additiveMiddle frontalR4.61104332933InsulaL4.14249−38−119Dorsal anterior cingulateR4.12182−92936Posterior cingulateL3.892950−4124Orbitofrontal gyrusL3.82100−951−29Basal forebrainL3.63236−113−17 TFR *ε4*-dominantDorsal anterior cingulateL4.56278−92735CuneusR4.3420420−7121Inferior TemporalL4.27270−54−39−17Superior temporalL4.23304−39−17−3InsulaR4.1441539−119Insula[a](#tf0025){ref-type="table-fn"}L4.02479−36−29PrecuneusR3.982079−4517Angular gyrusR3.8412629−5642RectusL3.84113−617−24Basal forebrainL3.73136−115−12RectusL3.63222−645−20 *ε4*-recessiveInferior temporalR4.8822757−44−14SMAR4.4335351256CuneusR4.1213618−7424Middle cingulateL3.86228−8−336Precuneus[a](#tf0025){ref-type="table-fn"}L3.80496−3−6229Paracentral lobuleL3.75158−8−2657Dorsal anterior cingulateL3.63125−92735PrecuneusL3.57104−11−4811Cerebellum lob. 6R3.4414130−63−21 *ε4*-additiveInferior temporalR4.7421957−45−12CuneusR4.5320720−7223Dorsal anterior cingulate[a](#tf0025){ref-type="table-fn"}L4.39529−92735Inferior temporalL4.12120−53−39−17SMAR4.1029231157Middle occipital gyrusL4.08112−47−78−2Posterior cingulate[a](#tf0025){ref-type="table-fn"}L4.0110630−5430InsulaL3.88212−36−20−5Entorhinal cortexR3.8513023−2−36Basal forebrainL3.66100−113−17 TDPR *ε4*-dominantDorsal anterior cingulateL4.38329−92736PrecuneusL4.161350−5632Middle fontal gyrusR4.15104332933Rolandic operculumL4.14442−39−99InsulaR4.0020439−119Frontal operculumR3.98199411512Basal forebrain[a](#tf0025){ref-type="table-fn"}L3.95480−113−17Fusiform gyrusL3.66190−35−11−41 *ε4*-recessiveSMAR4.4916751254Frontal operculumR3.86107421411Dorsal anterior cingulateL3.66110−92936Basal forebrainL3.38123−314−15 *ε4*-additiveSMAR4.3717061254Frontal operculumR4.20166411512Dorsal anterior cingulateL4.20316−92736InsulaL4.00172−38−1111Basal forebrain[a](#tf0025){ref-type="table-fn"}L4.00523−113−17InsulaR3.9110341−119 TDFR *ε4*-dominantBasal forebrainL4.20288−113−15InsulaR4.0844638−12−3Caudate nucleusR4.02358362InsulaL3.95106−32−315Superior temporal[a](#tf0025){ref-type="table-fn"}L3.94486−39−17−3 *ε4*-recessiveInferior temporal[a](#tf0025){ref-type="table-fn"}R4.7717357−44−14SMAR4.2830061256Dorsal anterior cingulateR3.8913003232PrecuneusL3.82122−3−6330Posterior cingulateR3.602729−3830PrecuneusR3.5817212−4711 *ε4*-additiveInferior temporalR4.2410957−45−12Dorsal anterior cingulateL4.1117903232SMAR4.0526281254Basal forebrainL3.96193−113−17PrecuneusL3.94223−3−6330InsulaL3.79172−36−20−5Posterior cingulateR3.331078−4424[^5][^6][^7][^8]Fig. 1*APOE*-ε4 risk variant modulated the associations between paired recall and gray matter volume.A) and B) Voxel-wise volumetric maps showing the dominant, recessive and additive effects of *APOE*-ε4 in modulating the association between immediate as well as delayed paired recall (TPR, TDPR) and gray matter structure For visualization purposes parametric maps are thresholded at *p* \< .005 with a cluster extent threshold of 100 voxels. C) and D) Group scatterplots in selected brain regions showing the significant interactions between immediate as well as delayed paired recall performance (TPR, TDPR) and *APOE*-ε4 status. Values of gray matter volume were extracted on the voxel level (cluster\'s local maximum) and adjusted for the covariates in the model (*i.e.*, age, sex, years of education and total intracranial volume). Pearson\'s correlation coefficients are shown on top of scatterplots for each subgroup. \**p* \< .05, \*\**p* \< .01, two-tailed. Shaded areas indicate 90% confidence intervals. ACC: Anterior cingulate cortex; BFCN: Basal forebrain cholinergic nuclei; PCC: Posterior cingulate cortex.Fig. 1Fig. 2*APOE*-ε4 risk variant modulated the associations between free recall and gray matter volume.A) and B) Voxel-wise volumetric maps showing the dominant, recessive and additive effects of *APOE*-ε4 in modulating the association between delayed free recall (TFR, TDFR) and gray matter structure. For visualization purposes parametric maps are thresholded at p \< .005 with a cluster extent threshold of 100 voxels. C) and D) Group scatterplots in selected brain regions showing the significant interactions between immediate as well as delayed paired recall performance (TFR, TDFR) and *APOE*-ε4 status. Values of gray matter volume were extracted on the voxel level (cluster\'s local maximum) and adjusted for the covariates in the model (*i.e.*, age, sex, years of education and total intracranial volume). Pearson\'s correlation coefficients are shown on top of scatterplots for each subgroup. \*p \< .05, \*\*p \< .01, two-tailed. Shaded areas indicate 90% confidence intervals. PCC: Posterior cingulate cortex.Fig. 2Table 4*APOE*-ε4 significantly modulated the relationship between delayed retention and regional GMv.Table 4Brain regionLaterality*t*-value[⁎](#tf0030){ref-type="table-fn"}k[⁎⁎](#tf0035){ref-type="table-fn"}MNI coordinatesxyzShort-delay retention *ε4*-dominantInsula[a](#tf0040){ref-type="table-fn"}L5.05982−35−240Insula[a](#tf0040){ref-type="table-fn"}R4.90126142−20−6Middle temporalL4.71135−42−6911Inferior frontalR4.41220384118Hippocampus[a](#tf0040){ref-type="table-fn"}R4.2973214−6−24Posterior cingulate[a](#tf0040){ref-type="table-fn"}L4.28458−6−4726Hippocampus[a](#tf0040){ref-type="table-fn"}L4.05908−24−14−20Inferior parietalL4.00118−27−5454 *ε4*-recessiveEntorhinal cortexR4.1012924−14−36 *ε4*-additiveInferior frontalR4.21193393920Entorhinal cortexR4.0932324−14−36InsulaL4.05245−36−260Insula[a](#tf0040){ref-type="table-fn"}R3.8957035−232Cerebellum Lob. 8L3.84155−35−39−45Posterior cingulateL3.69119−9−4814HippocampusL3.63126−23−14−20Long-delay retention *ε4*-dominantMiddle cingulate[a](#tf0040){ref-type="table-fn"}R4.515630−3941Inferior parietalL4.39359−26−5356InsulaR4.0410442−20−6Posterior cingulateR4.041390−5630InsulaR3.7329032−2717InsulaL3.59182−36−1414 *ε4*-recessiveEntorhinal cortexR4.5120126−14−36Superior frontalR3.971819854Cerebellum Lob. 8L3.97123−33−39−45 *ε4*-additiveEntorhinal cortexR4.6020626−14−36Cerebellum Lob. 8L4.12186−33−39−45Superior frontalR4.102179856Posterior cingulateR3.911970−5630InsulaR3.5711632−2717[^9][^10][^11]Fig. 3Effects of the *APOE*-ε4 risk variant in modifying the association between memory retention and regional gray matter volume.A) Dominant, recessive and additive effects of *APOE*-ε4 in modulating the association between short- and long-delay retention (SDR, LDR) and regional gray matter volume. Significant clusters are projected over coronal slices. B) Group scatterplots in selected brain regions showing the significant interactions between SDR as well as LDR and *APOE*-ε4 status in the gray matter volume of hippocampus and entorhinal cortex, respectively. Values of gray matter volume were extracted on the voxel level (cluster\'s local maximum) and adjusted for the covariates in the model (*i.e.*, age, sex, years of education and total intracranial volume). Pearson\'s correlation coefficients are shown on top of scatterplots for each subgroup. \*p \< .05, \*\*p \< .01, two-tailed. Shaded areas indicate 90% confidence intervals.Fig. 3

3.4. Impact of *APOE*-ε4 on the associations between EFs performance and GMv {#s0060}
----------------------------------------------------------------------------

*APOE*-ε4 modulated the association between GMv and efficiency in EFs. Of the administered tests, we detected significant interactions for the Coding, digit-span sequencing and the Visual Puzzles ([Table 5](#t0025){ref-type="table"}). [Fig. 4](#f0020){ref-type="fig"} displays these effects in selected brain regions. For the Coding test, the three genotypic models yielded significant effects in a set of common brain regions including the lateral as well as medial orbitofrontal cortex and the precentral gyrus. For the digit-span sequencing, we observed significant effects in the caudate nucleus (both recessive and additive models) and the middle orbital gyrus (recessive model). Finally, for the VP, significant interaction effects were observed in the postcentral gyrus (both recessive and additive models) and the superior frontal cortex (additive model).Table 5*APOE-ε4* significantly modulated the relationship between EFs performance and regional GMv.Table 5Brain regionLaterality*t*-value[⁎](#tf0045){ref-type="table-fn"}k[⁎⁎](#tf0050){ref-type="table-fn"}MNI coordinatesExecutive function Coding *ε4*-dominantLateral orbitofrontal[a](#tf0055){ref-type="table-fn"}R4.845303945−12Precentral gyrusL4.50193−39−648Superior orbitofrontalR3.851482138−15Medial orbitofrontalL3.78101−216−17 *ε4*-recessiveMedial orbitofrontal[a](#tf0055){ref-type="table-fn"}L5.581980−216−17Lateral orbitofrontal[a](#tf0055){ref-type="table-fn"}R5.1313934144−11Precentral gyrus[a](#tf0055){ref-type="table-fn"}L4.78357−41−648Lateral orbitofrontal[a](#tf0055){ref-type="table-fn"}L4.45548−4251−5Anterior cingulateL3.95257−12422Middle cingulateR3.952008−3042Rectal gyrusR3.63212635−14 *ε4*-additiveLateral orbitofrontal ^a^R5.3613393945−12Medial orbitofrontal[a](#tf0055){ref-type="table-fn"}L5.24870−216−17Precentral gyrus[a](#tf0055){ref-type="table-fn"}L5.01324−39−648Lateral orbitofrontalL4.46441−4451−5Medial orbitofrontal[a](#tf0055){ref-type="table-fn"}R4.35459216−18 DSS *ε4*-recessiveMiddle orbital gyrusL4.08380−1554−14Caudate nucleusL3.74202−12818 *ε4*-additiveCaudate nucleusL3.89279−14818Caudate nucleusR3.53168121117 VP *ε4*-recessivePostcentral gyrus[a](#tf0055){ref-type="table-fn"}L4.80620−27−4454 *ε4*-additivePostcentral gyrus[a](#tf0055){ref-type="table-fn"}L4.38451−27−4456Superior frontalL3.86180−175621[^12][^13][^14][^15]Fig. 4*APOE*-ε4 risk variant modulated the associations between cognitive processing speed (CPS) and gray matter volume.A) Dominant, recessive and additive effects of *APOE*-ε4 in modulating the association between short- and long-delay retention (SDR, LDR) and regional gray matter volume. Significant clusters are projected over coronal slices. For visualization purposes parametric maps are thresholded at p \< .005 with a cluster extent threshold of 100 voxels. B) Group scatterplots in selected brain regions showing the significant interactions between CPS performance and *APOE*-ε4 status. Values of gray matter volume were extracted on the voxel level (cluster\'s local maximum) and adjusted for the covariates in the model (*i.e.*, age, sex, years of education and total intracranial volume). Pearson\'s correlation coefficients are shown on top of scatterplots for each subgroup. \*p \< .05, \*\*p \< .01, two-tailed. Shaded areas indicate 90% confidence intervals. OFC: Orbitofrontal cortex; MCC: Middle cingulate gyrus.Fig. 4

The direction of these interaction effects was opposite compared to that observed for EM (*i.e.*, *APOE*-ε4 shifted the relationships from being positive to negative). A confirmatory analysis performed on the first principal component for both EM and EFs yielded similar results (Supplementary Table 4).

4. Discussion {#s0065}
=============

We report that the *APOE* genotype modifies the association between cognitive performance and the underlying cerebral morphology as expressed by regional GMv, in cognitively healthy individuals. In both domains of EM and EFs, *APOE*-ε4 carriers displayed reversed relationships between regional brain volumes and cognitive performance in a highly symmetrical topological pattern. More specifically, presence of *APOE*-ε4 shifted the associations between EM and regional GMv from negative to positive, while driving the opposite effect on the relationship with EFs. These effects resemble those observed in our previous study, where we reported a qualitatively similar modulatory role for aging in modifying the structure-function relationship ([@bb0060]). In our earlier report, we found that older age shifted the association between GMv and EM performance from being negative to positive, corroborating findings by other research groups ([@bb0395]).We proposed that, while for younger individuals reduced brain volumes in dedicated brain areas may be the result of successful neurodevelopmental events which increase efficiency (*e.g.*, synaptic pruning), larger GMv in advanced age would represent a proxy for available brain reserve, therefore supporting memory performance. Following this postulate, the results of the present study suggest that *APOE*-ε4 carriers display a pattern of structure-function association corresponding to an older age than their chronological one. If so, our data would provide a biological underpinning for the hypothesis that *APOE*-ε4 confers an accelerated aging process in the brain ([@bb0055]; [@bb0125]; [@bb0140]). In line with this, longitudinal studies reported a faster age-related decline of episodic memory in unimpaired *APOE*-ε4 carriers, with a gene-dose dependent effect ([@bb0065]). Alternatively, our interaction data may be indicative of age-independent neurodevelopmental effects of the ε4 allele on the brain morphology ([@bb0105]; [@bb0075]), which may lead to a distinctive cerebral organization supporting cognitive functioning during the entire lifespan. Additionally, it may be that a proportion of our ε4-homozygous individuals have already entered the preclinical stage of AD, with the pathology possibly affecting the structural network underlying cognition. This latter consideration remains however uncertain given the lack of core AD biomarkers in the current study.

The dissociation we found between cerebral volumes and performance in EM *vs.* EFs resembles that of our former study conducted in a subsample of the present one, where we observed negative relationships for EM but positive correlations for EFs ([@bb0060]). This divergence is reconciled if one considers that the brain structures supporting EM (*i.e.*, medial temporal lobe) and EFs (prefrontal cortex) display different time-course maturation patterns, with medial temporal lobe rapidly evolving during childhood, while prefrontal areas reaching complete maturation only in the adulthood ([@bb0160]). Therefore, compared to prefrontal areas, medial temporal lobe regions may be more subject to neurodevelopmental events such as synaptic pruning, which optimize neural computational efficiency ([@bb0375]). Besides, the observed dissociation on the brain structure level, was already reported in functional MRI studies which have observed deactivation in "task-negative" networks during successful encoding ([@bb0230]), while observing an increase of activation in the executive control network supporting EFs ([@bb0285]).

In the analysis of EM, we found that the three genotypic models mapped onto common brain regions, such as the dorsal anterior cingulate and the inferior temporal gyrus. However, for TPR and TDFR there were no shared brain regions between the dominant and the recessive models. The same was true for SDR and LDR, indicating that these two models were associated to distinct brain structural imaging phenotypes. Across all the MBT outcomes, the additive model, which assumes an increased genetic penetrance according to the number of risk alleles, yielded significant effects in the right and left basal forebrain cholinergic nuclei (BFCN) ([@bb0415]). These consist of four nuclei which provide the major cholinergic source to the hippocampus and prefrontal areas ([@bb0265]). Cholinergic signaling in the CNS ensures cortical activation, promotes vigilance, and supports cognitive effort during attentional tasks ([@bb0015]). Importantly, BFCN undergo progressive degeneration during the course of AD ([@bb0380]) and previous studies detected BCFN atrophy prior to the onset of cognitive symptoms in healthy individuals who later converted to AD ([@bb0350]; [@bb0185]; [@bb0190]). Additionally, [@bb0200] reported that the thickness of the BFCN positively correlated with global cognition in AD, but not in other forms of dementia, suggesting that cognitive dysfunction in AD is at least partially attributable to cholinergic dysfunction. Similarly, [@bb0155] reported significantly positive associations in mild cognitive impairment (MCI) and AD patients, between BFCN volume and immediate as well as delayed recall assessed using a similar memory paradigm as ours. Hence our results suggest that, unlike in non-carriers, EM efficiency in individuals at higher genetic risk for AD depends on the integrity of brain structures which overlap with those in AD patients, although being within normal ranges. Importantly, an abnormal pattern of age-related BCFN structural degeneration has been shown to parallel Aβ positivity in cognitively healthy people ([@bb0355]). Thus, it may be that among our healthy ε4-homozygous, those having lower BFCN volumes and consequently worse EM, may display Aβ deposition and have already entered a preclinical stage of AD. However, the lack of biomarker data in our study prevents us to draw such a conclusion.

Other brain regions that were identified by the additive model across the four recall outcomes of the MBT were the bilateral insula and the dorsal anterior cingulate cortex, both central nodes of the previously described salience network ([@bb0360]). The insula displays reciprocal connections with the BFCN ([@bb0420]), and prior studies have highlighted its involvement in performance monitoring ([@bb0095]) and error awareness ([@bb0235]). In this framework, our findings suggest that *APOE*-ε4 carriers rely on the integrity of multiple compensatory brain systems in order to achieve an equivalent memory performance to non-carriers, possibly due to an incipient degeneration of brain areas supporting cognitive performance ([@bb0055]: [@bb0300]).In line with this, previous functional MRI studies have consistently show that early-middle age cognitively healthy *APOE*-ε4 carriers display hyperactivation in temporal and frontal areas during episodic as well as working memory tasks ([@bb0140]; [@bb0020]; [@bb0025]; [@bb0405]) which has been interpreted as signature of neural compensation (see [@bb0195] for a review). This view is further corroborated by previous studies which have proposed the BFCN as a substrate for neuronal adaptation. With this respect, [@bb0100] found that cholinergic input to temporal regions facilitates the recovery of function after structural damage to the circuitry mediating episodic memory. [@bb0320] showed that patients with MCI present a shift from fornix- to parahippocampal-based circuitry in order to preserve their residual memory, and that this reallocation was dependent on the volume of the BFCN. The recessive model yielded significant interaction effects predominantly in midline cortical areas spanning from the dorsal anterior (TFR, TDPR) to the posterior cingulate gyrus (TPR), including the precuneus (TFR). For measures of immediate and delayed free recall, the recessive model also returned significant interactions in the inferior temporal regions. All these regions are subject to early accumulation of fibrillary Aβ in healthy *APOE*-ε4 carriers ([@bb0345]) with these effects being highest in ε4-homozygous ([@bb0335]). Additionally, lower glucose metabolism in the precuneus and posterior cingulate cortex has been observed in relation to the number of ε4 alleles in cognitively intact individuals ([@bb0315]; [@bb0330]). Thus, our recessive model seems pointing to areas that are specifically vulnerable to Aβ deposition. Notably, cognitively intact subjects with cerebral Aβ burden in midline cortical areas display over-activation in task-positive networks during recall and this hyperactivity correlates with recall precision, indicating a mechanism of neural compensation ([@bb0115]). It is therefore plausible that a similar mechanism is operating in our ε4-homozygous subjects given the close association between *APOE*-ε4 homozygosity and brain amyloidosis. In fact, at the mean age in our sample, about 50% of ε4-homozygous are expected to harbor Aβ pathology ([@bb0215]).

In addition to immediate and delayed recall, we computed the percentage of retained words after short and long delay with respect to the number of encoded items. Delayed retention provides different information compared to recall, because it is controlled for potential encoding-related effects and it is relatively unaffected by aging ([@bb0035]). We could confirm that, unlike recall outcomes, both SDR and LDR were unaffected by advancing age (Supplementary Fig. 3). Earlier studies have shown that deficient delayed retention predicts the onset of dementia years before ([@bb0245]; [@bb0110]). We did not observe a significant impact of *APOE*-ε4 on delayed retention performance, however we did observe interaction effects similar to that described for recall measures, although with a partially different topology. For SDR the interaction involved the head of hippocampus bilaterally, which additionally survived FWE correction on the cluster level. For LDR we observed a significant interaction in the right entorhinal cortex. The specificity of delayed retention measures may have engaged a compensatory strategy in these areas. Yet, other mechanisms apart from compensation may underlie these interactions, since SDR and LDR were the only two outcomes of EM where the homozygote group tended to perform worse than the rest, possibly indicating an incipient failure of compensatory strategies for this specific facet of EM (Supplementary Fig. 1).

We next examined EFs and found that *APOE*-ε4 shifted the association between GMv and performance on cognitive processing speed (CPS, assessed with the Coding test) as well as working memory (assessed through the digit-span sequencing) from being positive to negative, again mirroring our previous data on the interaction between executive functions and aging ([@bb0060]). Effects for CPS included orbitofrontal, prefrontal and middle cingulate cortex across the three genotypic models, although the strongest significance values were observed in the recessive and additive models where several regions survived FWE correction. CPS efficiency depends on the integrity of white matter fibers ([@bb0030]; [@bb0240]) and we have recently shown white matter microstructural degeneration in the homozygote group of the present sample ([@bb0300]). It is possible that, due to inefficient recruitment of white matter circuitry, reduced GMv in orbitofrontal areas aids processing speed in *APOE*-ε4 homozygous. For example, the orbitofrontal cortex is considered a critical region for motor response inhibition ([@bb0040]; [@bb0340]), hence less volume in these areas would facilitate or sustain motor activation necessary for this task. Accordingly, a reduced volume in the middle cingulate gyrus would disengage conflict monitoring, supporting the execution of the psychomotor task ([@bb0310]; [@bb0365]). In support of this, increased thickness in frontal areas in healthy *APOE*-ε4 carriers predicted worse performance in attentional tasks ([@bb0120]). Alternatively, larger volume in prefrontal and orbitofrontal areas in *APOE*-ε4 homozygotes may be the result of incipient neuroinflamatory processes exacerbated by the ε4 allele ([@bb0410]), which in turn interferes with efficient executive functions.

Finally, we did not detect a significant impact of *APOE*-ε4 allele load on either memory or executive functions, in line with the lack of consistent findings in the literature on the effect of this risk variant on cognitive performance ([@bb0295]). Genetic epistasis as well as additional environmental factors may moderate the direct impact of *APOE* status on cognition and future research shall take these variables into consideration. As mentioned above, the lack of core AD biomarkers represents a limitation of the present study. The inclusion of these data would allow to disentangle whether the observed effects are further moderated by amyloid or tau positivity. Another limitation is represented by the cross-sectional nature of our study design. Since *APOE*-ε4 has been suggested to impact cognition differentially across life stages (*i.e.*, the antagonistic pleiotropy hypothesis, reviewed in [@bb0390]), longitudinal follow-up is required to delineate the lifetime trajectories of the interaction effects between cognition and *APOE* status.

In summary, our study provides novel insights on the mechanisms through which *APOE*-ε4 posits an increased risk for AD, by showing that presence of this risk allele modulates the association between cognitive function and the underlying gray matter morphology. Even though the assessed genotypic models revealed overlapping results, several brain regions were model-specific. However, the additive model was the one that better summarized the impact of the risk variant on our neuroimaging outcomes, as it captured a cerebral topology in conjunction with either the dominant or the recessive ones. This lends further support for the previously reported dose-dependent risk for AD exerted by the *APOE*-ε4 allele ([@bb0090]; [@bb0130]). Finally, our data suggest that cognitive efficiency may undergo continuous compensation during healthy aging and in individuals at risk for dementia, making difficult to bridge the gap between genes and cognition without considering the underlying biological endophenotype. Future research shall address what factors moderate successful neural compensatory strategies and when this starts to eventually lead to neurodegeneration.
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[^1]: TIV: Total intracranial volume; NC: Non-Carriers; HE: ε4-heterozygous; HO: ε4-homozygous.

[^2]: Indicated in years.

[^3]: Indicated in Cm^3^.

[^4]: TPR: Total paired recall; TFR: Total free recall; TDPR: Total delayed paired recall; TDFR: Total delayed free recall; SDR: Short-delay retention; LDR: Long-delay retention; DSF: Digit-span forward; DSB: Digit-span backwards; DSS: Digit-span sequence; VP: Visual Puzzles.

[^5]: MNI: Montreal Neurological Institute; TPR: Total paired recall; TFR: Total free recall; TDPR: Total delayed paired recall; TDFR: Total delayed free recall; SMA: Supplementary motor area.

[^6]: Significant at a whole-brain threshold of p \< .001, with a cluster size correction of 100 contiguous voxels.

[^7]: Cluster size indicated in number of contiguous voxels.

[^8]: Additionally survived correction for multiple testing on the cluster level (p \< .05) computed with a Family-Wise Error rate approach (FWE).

[^9]: Significant at a whole-brain threshold of *p* \< .001. with a cluster size correction of 100 contiguous voxels.

[^10]: Cluster size indicated in number of contiguous voxels.

[^11]: Additionally survived correction for multiple testing on the cluster level (p \< .05) computed with a Family-Wise Error rate approach (FWE).

[^12]: MNI: Montreal Neurological Institute; DSS: Digit-span sequencing; VP: Visual puzzles.

[^13]: Significant at a whole-brain threshold of p \< .001, with a cluster size correction of 100 contiguous voxels.

[^14]: Cluster size indicated in number of contiguous voxels.

[^15]: Additionally survived correction for multiple testing on the cluster level (p \< .05) computed with a Family-Wise Error rate approach (FWE).
